Trials / Completed
CompletedNCT04537845
Retrospective Analysis of PET Brain Imaging in Chronic Cancer Pain
FDG PET Imaging Study of Brain Metabolic Change in Chronic Cancer Pain Patient: a Retrospective Analysis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 119 (actual)
- Sponsor
- National Taiwan University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Cancer pain deteriorated in quality of life and related with numerous psychosocial problems. Over the one third of cancer patient suffered from moderate to severe cancer pain, even under adequate pain management. The 18F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) images can provide quantitative results in clinical oncology. As a functional neuroimaging, the PET evidently provided anatomical activated regions, size, and spatial extent information. In this retrospective study, we use FDG-PET to investigate changes concerning the glucose metabolism in the brain with or without cancer pain.
Conditions
Timeline
- Start date
- 2020-03-02
- Primary completion
- 2020-08-08
- Completion
- 2020-08-08
- First posted
- 2020-09-03
- Last updated
- 2022-09-21
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04537845. Inclusion in this directory is not an endorsement.